Citation Impact
Citing Papers
Validation of the Inflammatory Bowel Disease Disability Index in a population-based cohort
2015
Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa
2010 Standout
Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases
2007 Standout
Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients
2008 Standout
Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites
2009 Standout
The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation
2016
Reductions in 28-Day Mortality Following Hospital Admission for Upper Gastrointestinal Hemorrhage
2011 Standout
Oral 5-aminosalicylic acid for maintenance of medically-induced remission in Crohn's disease
2005
Maintenance treatment of Crohn's disease
2003
Factors Associated With Poor Outcomes in Adults With Newly Diagnosed Ulcerative Colitis
2014
An Update on the Epidemiology of Inflammatory Bowel Disease in Asia
2008
Predictive Factors of Response to Cyclosporine in Steroid-Refractory Ulcerative Colitis
2008
Environment and the Inflammatory Bowel Diseases
2013
European evidence based consensus on the diagnosis and management of Crohn’s disease: current management
2006
Probiotics—compensation for lactase insufficiency
2001
Systematic Review of Effects of Withdrawal of Immunomodulators or Biologic Agents From Patients With Inflammatory Bowel Disease
2015
Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis
2013 Standout
Increasing Incidence and Prevalence of the Inflammatory Bowel Diseases With Time, Based on Systematic Review
2011 Standout
Characteristics and Outcomes of Upper Gastrointestinal Hemorrhage in a Tertiary Referral Hospital
2010
Response to Corticosteroids in Severe Ulcerative Colitis: A Systematic Review of the Literature and a Meta-Regression
2006
Increased Response and Remission Rates in Short-Duration Crohn's Disease With Subcutaneous Certolizumab Pegol: An Analysis of PRECiSE 2 Randomized Maintenance Trial Data
2010
Relationship between lactose digestion, gastrointestinal transit time and symptoms in lactose malabsorbers after dairy consumption
2001
Rheumatoid arthritis
2016 Standout
Geographical variations of inflammatory bowel disease in France: A study based on national health insurance data
2006
Interferon-Induced Sarcoidosis
2006
Pediatric modification of the Montreal classification for inflammatory bowel disease
2010
The microbiota in adaptive immune homeostasis and disease
2016 StandoutNature
NLRP6 Inflammasome Regulates Colonic Microbial Ecology and Risk for Colitis
2011 Standout
Recent considerations in nonsteroidal anti-inflammatory drug gastropathy
1998
Ulcerative Colitis
2011 Standout
Clustering in time of familial IBD separates ulcerative colitis from Crohnʼs disease
2009
Transfusion Strategies for Acute Upper Gastrointestinal Bleeding
2013 Standout
Human Genetics Shape the Gut Microbiome
2014 Standout
European evidence based consensus for endoscopy in inflammatory bowel disease
2013 Standout
Unravelling the pathogenesis of inflammatory bowel disease
2007 StandoutNature
Long-term Outcome of Treatment with Intravenous Cyclosporin in Patients With Severe Ulcerative Colitis
2004
Natural history of Crohn's disease in a population-based cohort from Cardiff (1986–2003): a study of changes in medical treatment and surgical resection rates
2010
Antibiotic-associated diarrhoea
2004
Consensus Statements on the Risk, Prevention, and Treatment of Venous Thromboembolism in Inflammatory Bowel Disease: Canadian Association of Gastroenterology
2014
Comparison of Upper Gastrointestinal Toxicity of Rofecoxib and Naproxen in Patients with Rheumatoid Arthritis
2000 Standout
Influence of Immunogenicity on the Long-Term Efficacy of Infliximab in Crohn's Disease
2003 Standout
Use of thiopurines in inflammatory bowel disease: Safety issues
2014
Olsalazine is not superior to placebo in maintaining remission of inactive Crohn's colitis and ileocolitis: a double blind, parallel, randomised, multicentre study
2001
Capsule endoscopy: Present status and future expectation
2014
Inflammatory bowel disease: clinical aspects and established and evolving therapies
2007 Standout
Ulcerative Colitis Practice Guidelines in Adults (Update): American College of Gastroenterology, Practice Parameters Committee
2004 Standout
Crohn's disease
2012 Standout
Patchy distribution of mucosal lesions in ileal Crohnʼs disease is not linked to differences in the dominant mucosa-associated bacteria
2006
Pregnancy and the Patient with Inflammatory Bowel Disease
2016
Ulcerative colitis
2002
A Short-Term Study of Chimeric Monoclonal Antibody cA2 to Tumor Necrosis Factor α for Crohn's Disease
1997 Standout
Factors predictive of response to cyclosporin treatment for severe, steroid-resistant ulcerative colitis
2000
Epidemiology and risk factors for IBD
2015 Standout
Liver dysfunction associated with artificial nutrition in critically ill patients
2007
Inflammatory Bowel Disease
2009 Standout
Early Administration of Azathioprine vs Conventional Management of Crohn's Disease: A Randomized Controlled Trial
2013
Genetics of Inflammatory Bowel Diseases
2015
Disease Activity Courses in a Regional Cohort of Crohn's Disease Patients
1995
Mechanisms and Management of Antibiotic‐Associated Diarrhea
1998
European evidenced-based consensus on reproduction in inflammatory bowel disease
2010
Short Bowel Syndrome and Intestinal Failure in Crohnʼs Disease
2016
Host Remodeling of the Gut Microbiome and Metabolic Changes during Pregnancy
2012 Standout
Epidemiology of pediatric inflammatory bowel disease: A systematic review of international trends
2010
Prophylaxis of postoperative relapse in Crohn's disease with mesalamine: European cooperative Crohn's disease study VI
2000
Impact of the increasing use of immunosuppressants in Crohn’s disease on the need for intestinal surgery
2005
Vaccination strategies for patients with inflammatory bowel disease on immunomodulators and biologics
2009
The burden of inflammatory bowel disease in Europe
2013
Crohn's disease
2016 Standout
Inflammatory Bowel Disease
2002 Standout
Risk of Surgery for Inflammatory Bowel Diseases Has Decreased Over Time: A Systematic Review and Meta-analysis of Population-Based Studies
2013
Inflammatory Bowel Disease
1991
Sarcoidosis in Patients With Chronic Hepatitis C Virus Infection
2005
Incidence of inflammatory bowel disease in finnish children, 1987–2003
2006
Epidemiology of inflammatory bowel disease
2002
Drug-Induced Diarrhoea
2000
Endoscopy in inflammatory bowel disease: Indications, surveillance, and use in clinical practice
2005
AGA technical review on parenteral nutrition
2001
Preventing Postoperative Recurrence in Crohn’s Disease: What Does the Future Hold?
2013
Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial
2002 Standout
Endoscopy in inflammatory bowel disease
2002
Early azathioprine/biological therapy is associated with decreased risk for first surgery and delays time to surgery but not reoperation in both smokers and nonsmokers with Crohnʼs disease, while smoking decreases the risk of colectomy in ulcerative colitis
2010
Mucosal Healing in Inflammatory Bowel Disease: Results From a Norwegian Population-Based Cohort
2007
European evidence-based Consensus on the management of ulcerative colitis: Special situations
2008
ASGE guideline: endoscopy in the diagnosis and treatment of inflammatory bowel disease
2006
Maintenance Treatment With Azathioprine in Ulcerative Colitis: Outcome and Predictive Factors After Drug Withdrawal
2009
Clinical Risk Factors for Complicated Disease: How Reliable Are They?
2012
Randomized, double-blind comparison of 4 mg/kg versus 2 mg/kg intravenous cyclosporine in severe ulcerative colitis1 1Gert Van Assche, Severine Vermeire, Geert D’Haens, and Paul Rutgeerts have been instrumental in the design of the study, trial management, data analysis, and writing the paper. Maja Noman had a major contribution in the clinical ambulatory follow-up of the patients in the trial. Martin Hiele followed cyclosporine levels and adjusted drug doses of patients in the trial and provided statistical advice. Katrien Asnong was the study coordinator and had a major share in data analysis. Joris Arts analyzed safety data and followed patients clinically during the trial. Andre D’Hoore and Freddy Penninckx performed the surgical interventions in patients failing the trial and substantially contributed in evaluating patients for colectomy.
2003
Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 2: Current management
2012
Inflammatory bowel disease in the Asia–Pacific area: A comparison with developed countries and regional differences
2010
Impact of azathioprine and tumour necrosis factor antagonists on the need for surgery in newly diagnosed Crohn's disease
2011
Ulcerative colitis
2016 Standout
Gut flora in health and disease
2003 Standout
Pharmacokinetic Considerations in the Treatment of Inflammatory Bowel Disease
2001
Gastrointestinal Toxicity of Nonsteroidal Antiinflammatory Drugs
1999 Standout
Predictors of Infliximab Failure After Azathioprine Withdrawal in Crohn's Disease Treated With Combination Therapy
2010
The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management
2010
Inflammatory Bowel Disease
1996
Ulcerative Colitis Practice Guidelines in Adults: American College of Gastroenterology, Practice Parameters Committee
2010
Family and twin studies in inflammatory bowel disease
2006
Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 1: Definitions and diagnosis
2012
Comparative effectiveness of azathioprine in Crohn’s disease and ulcerative colitis: prospective, long‐term, follow‐up study of 394 patients
2008
A metaanalysis of treatment outcomes of early enteral versus early parenteral nutrition in hospitalized patients*
2005
Microbiota Modulate Behavioral and Physiological Abnormalities Associated with Neurodevelopmental Disorders
2013 Standout
Nationwide prevalence and drug treatment practices of inflammatory bowel diseases in Hungary: A population-based study based on the National Health Insurance Fund database
2016
MEDICAL THERAPY FOR INFLAMMATORY BOWEL DISEASE
1999
Azathioprine and 6-Mercaptopurine for the Prevention of Postoperative Recurrence in Crohn's Disease: A Meta-Analysis
2009
Genetics and pathogenesis of inflammatory bowel disease
2011 StandoutNature
Nutritional Support
1997
Intravenous cyclosporine versus intravenous corticosteroids as single therapy for severe attacks of ulcerative colitis
2001
Role of genetic and environmental factors in British twins with inflammatory bowel disease
2011
Accuracy of Magnetic Resonance Enterography in Assessing Response to Therapy and Mucosal Healing in Patients With Crohn's Disease
2013
The Toronto Consensus Statements for the Management of Inflammatory Bowel Disease in Pregnancy
2015
Tumour necrosis factor α and interleukin 1β in relapse of Crohn's disease
1999
Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies
2017 Standout
The Second European Evidenced-Based Consensus on Reproduction and Pregnancy in Inflammatory Bowel Disease
2014
Current and future diagnostic approaches: From serologies to imaging
2007
Systematic review: the use of ultrasonography, computed tomography and magnetic resonance imaging for the diagnosis, assessment of activity and abdominal complications of Crohn’s disease
2011
Early versus Late Parenteral Nutrition in Critically Ill Adults
2011 Standout
Bleeding Peptic Ulcer
1994 Standout
Increased Risk of Venous Thromboembolic Events With Corticosteroid vs Biologic Therapy for Inflammatory Bowel Disease
2014
Epidemiology and Natural History of Inflammatory Bowel Diseases
2011 Standout
Epidemiology of inflammatory bowel disease in a German twin cohort: Results of a nationwide study
2008
5-Aminosalicylates and renal function in inflammatory bowel disease
2007
Sarcoidosis
2007 Standout
Basiliximab (anti‐CD25) in combination with steroids may be an effective new treatment for steroid‐resistant ulcerative colitis
2003
Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease
2010
Infliximab in severe ulcerative colitis: short‐term results of different infusion regimens and long‐term follow‐up
2007
Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease
2010 Standout
5-Aminosalicylates and Effects on Renal Function in Patients with Crohnʼs Disease
2005
Medical therapy for ulcerative colitis
2000
Review article: the role of bacteria in onset and perpetuation of inflammatory bowel disease
2006
Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
2013 Standout
Frailty in elderly people
2013 Standout
Scheduled maintenance treatment with infliximab is superior to episodic treatment for the healing of mucosal ulceration associated with Crohn's disease
2006
American Gastroenterological Association Institute Technical Review on Corticosteroids, Immunomodulators, and Infliximab in Inflammatory Bowel Disease
2006
Management of Crohn's Disease in Adults
2009 Standout
Disorders of a modern lifestyle: reconciling the epidemiology of inflammatory bowel diseases
2008
Highlighting new phylogenetic specificities of Crohnʼs disease microbiota
2010
Pretreatment serum albumin as a predictor of cancer survival: A systematic review of the epidemiological literature
2010 Standout
A review of activity indices and efficacy endpoints for clinical trials of medical therapy in adults with Crohn's disease
2002
Antibiotic-Associated Diarrhea
2002 Standout
Effect of an Enteric-Coated Fish-Oil Preparation on Relapses in Crohn's Disease
1996
Intensive Insulin Therapy in Critically Ill Patients
2001 Standout
Azathioprine and mesalamine for prevention of relapse after conservative surgery for Crohn’s disease
2004
A global consensus on the classification, diagnosis and multidisciplinary treatment of perianal fistulising Crohn's disease
2014
The limitations of corticosteroid therapy in Crohn’s disease
2001
Fine-scale geographic variations of inflammatory bowel disease in France: Correlation with socioeconomic and house equipment variables
2009
Intensive Insulin Therapy in the Medical ICU
2006 Standout
Immunomodulators Are Associated With a Lower Risk of First Surgery Among Patients With Non-Penetrating Non-Stricturing Crohn's Disease
2009
Depression and anxiety in inflammatory bowel disease: A review of comorbidity and management
2009
Endoscopic evaluation of patients with inflammatory bowel disease
2008
The Clustering of Other Chronic Inflammatory Diseases in Inflammatory Bowel Disease: A Population-Based Study
2005
Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis
2005 Standout
An Evidence-Based Systematic Review on Medical Therapies for Inflammatory Bowel Disease
2011
Systematic review: monotherapy with antitumour necrosis factor α agents versus combination therapy with an immunosuppressive for IBD
2014
IOIBD technical review on endoscopic indices for Crohn's disease clinical trials
2015
Relation of upper gastrointestinal bleeding to non-steroidal anti-inflammatory drugs and aspirin: a case-control study.
1991
Nutritional interventions for preventing and treating pressure ulcers
2014
Endpoints for clinical trials evaluating disease modification and structural damage in adults with Crohnʼs disease
2009
Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation
2010 Standout
Review article: the natural history of postoperative C rohn's disease recurrence
2012
Never underestimate inflammatory bowel disease: High prevalence rates and confirmation of high incidence rates in Australia
2015
Environmental risk factors for inflammatory bowel disease.
2010
Maintenance Therapy in Crohn's Disease
2000
Video capsule endoscopy in inflammatory bowel disease
2010
Clinical Practice Guideline for the Surgical Management of Crohn’s Disease
2015
Course of Crohn's disease after allogeneic marrow transplantation
1998
N,N-DIMETHYLFORMAMIDE: HAZARD CHARACTERIZATION AND EXPOSURE–RESPONSE ANALYSIS
2001
[American Gastroenterological Association Institute technical review on corticosteroids, immunomodulators, and infliximab in inflammatory bowel disease].
2007
Systematic review with meta‐analysis: mucosal healing is associated with improved long‐term outcomes in Crohn's disease
2015
European evidence-based Consensus on the diagnosis and management of ulcerative colitis: Definitions and diagnosis
2008
Oral 5-aminosalicylic acid for maintenance of medically-induced remission in Crohn's disease
2016
Luminescent metal–organic frameworks for chemical sensing and explosive detection
2014 Standout
Association of Mycobacterium avium subspecies paratuberculosis With Crohn Disease in Pediatric Patients
2011
Iron-Deficiency Anemia
2015 Standout
Enteral nutritional therapy for induction of remission in Crohn's disease
2007
Risks and Benefits of Nutritional Support During Critical Illness
2006
European Evidence-based Consensus: Inflammatory Bowel Disease and Malignancies
2015
Eukaryotic-Microbiota Crosstalk: Potential Mechanisms for Health Benefits of Prebiotics and Probiotics
2008
A Review of Activity Indices and Efficacy End Points for Clinical Trials of Medical Therapy in Adults With Ulcerative Colitis
2006 Standout
Traditional corticosteroids for induction of remission in Crohn's disease
2008
European evidence-based Consensus on the management of ulcerative colitis: Current management
2008
Inflammatory Bowel Disease Increases Risk of Adverse Pregnancy Outcomes: A Meta-Analysis
2015
Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis
2016
Predicting complicated Crohn's disease and surgery: phenotypes, genetics, serology and psychological characteristics of a population-based cohort
2013
Molecular Origin of Blood‐Based Infrared Spectroscopic Fingerprints**
2021 StandoutNobel
Azathioprine or 6-mercaptopurine for maintenance of remission in Crohn's disease
2015
Cancers Complicating Inflammatory Bowel Disease
2015
Works of Éric Lerebours being referenced
Natural history of elderly-onset inflammatory bowel disease: a population-based cohort study
2013
Controlled trial of bowel rest in the treatment of severe acute colitis.
1986
Clinical predictors at diagnosis of disabling pediatric Crohnʼs disease
2012
Mortality and Cancer in Pediatric-Onset Inflammatory Bowel Disease: A Population-Based Study
2013
Pregnancy outcome in patients with inflammatory bowel disease treated with thiopurines: cohort from the CESAME Study
2010
Changes in characteristics and outcome of acute upper gastrointestinal haemorrhage: a comparison of epidemiology and practices between 1996 and 2000 in a multicentre French study
2005
Azathioprine Withdrawal in Patients With Crohn's Disease Maintained on Prolonged Remission: A High Risk of Relapse
2008
Fistulizing perianal Crohnʼs disease
2010
A Randomized, Double-Blind, Controlled Withdrawal Trial in Crohn’s Disease Patients in Long-term Remission on Azathioprine
2005
Crohn’s disease patients with chronic intestinal failure receiving long-term parenteral nutrition: a cross-national adult study
2011
Long-term outcome of treatment with infliximab in pediatric-onset Crohnʼs disease: A population-based study
2011
Excess primary intestinal lymphoproliferative disorders in patients with inflammatory bowel disease
2012
Endoscopic monitoring of Crohn's disease treatment: A prospective, randomized clinical trial
1992
Inflammatory bowel disease in spouses and their offspring
2001
Intravenous cyclosporine in attacks of ulcerative colitis
1996
Clinical Evaluation of the Use of the M2A Patency Capsule System Before a Capsule Endoscopy Procedure, in Patients with Known or Suspected Intestinal Stenosis
2005
Prognosis of patients with nonmalignant chronic intestinal failure receiving long-term home parenteral nutrition
1995
The Natural History of Pediatric Ulcerative Colitis: A Population-Based Cohort Study
2009
Prothrombotic Inherited Abnormalities Other Than Factor V Leiden Mutation Do Not Play a Role in Venous Thrombosis in Inflammatory Bowel Disease
2001
Ineffectiveness of Lactobacillus johnsonii LA1 for prophylaxis of postoperative recurrence in Crohn’s disease: a randomised, double blind, placebo controlled GETAID trial
2005
The changing pattern of Crohn’s disease incidence in northern France: a continuing increase in the 10- to 19-year-old age bracket (1988-2007)
2011
Efficacy and safety of ornithine alpha-ketoglutarate in heel pressure ulcers in elderly patients: Results of a randomized controlled trial
2009
Oral mesalamine (Pentasa) as maintenance treatment in Crohn's disease: A multicenter placebo-controlled study
1993
Predicting Factors of Fistula Healing and Clinical Remission After Infliximab-Based Combined Therapy for Perianal Fistulizing Crohn’s Disease
2008
Stressful Life Events as a Risk Factor for Inflammatory Bowel Disease Onset: A Population-Based Case–Control Study
2006
Baseline Nutritional Status Is Predictive of Response to Treatment and Survival in Patients Treated by Definitive Chemoradiotherapy for a Locally Advanced Esophageal Cancer
2007
Placebo-controlled clinical trial of mesalazine in the prevention of early endoscopic recurrences after resection for Crohnʼs disease
1996
Treatment of Crohn's disease by lymphocyte apheresis: A randomized controlled trial
1994
Renal impairment in patients with inflammatory bowel disease: association with aminosalicylate therapy?
2004
Value of wireless capsule endoscopy in patients with indeterminate colitis (inflammatory bowel disease type unclassified)
2006
Mapping of inflammatory bowel disease in northern France: Spatial variations and relation to affluence
2009
Identifying patients with a high risk of relapse in quiescent Crohn's disease. The GETAID Group. The Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives.
1995
[Cost of early management of chronic inflammatory intestinal disease].
1999
105 Natural History of Ulcerative Colitis in the Elderly: A Population-Based Study
2012
Decreased brush border hydrolase activities without gross morphologic changes in human intestinal mucosa after prolonged total parenteral nutrition of adults
1986
[Severe diarrhea caused by Ticlid associated with disorders of small intestine motility].
1989
Endoscopic healing of Crohn's Ileo-colitis with azathioprine
2003
[Acute hepatic disorders after exposure to dimethylformamide. Clinical and histological aspects].
1993
Incidence, Clinical Presentation and Location at Diagnosis of Pediatric Inflammatory Bowel Disease: A Prospective Population‐Based Study in Northern France (1988‐1999)
2005
Which patients taking non-aspirin non-steroidal anti-inflammatory drugs bleed? A case-control study.
1995
[Upper gastrointestinal hemorrhage caused by anti-inflammatory agents].
1989
Natural History of Pediatric Crohn's Disease: A Population-Based Cohort Study
2008
Early Surgery is Not Associated With Poor Prognosis in Pediatric Crohn's Disease: A Population-Based Study
2011
[Maintenance treatment of Crohn's disease using orally administered mesalazine (Pentasa). A controlled multicenter study. The Study Groups on the Treatment of Inflammatory Digestive Disorders].
1993
Yogurt and fermented-then-pasteurized milk: effects of short-term and long-term ingestion on lactose absorption and mucosal lactase activity in lactase-deficient subjects
1989
Hepatic Alterations During Total Parenteral Nutrition in Patients with Inflammatory Bowel pisease: A Possible Consequence of Lithocholate Toxicity
1982
Effects of amoxicillin-clavulanate combination on the motility of the small intestine in human beings
1991
P137 Long-term outcome of paediatric-onset Crohn's disease: A population-based study
2012
[Incidence of inflammatory bowel disease in the Nord-Pas-de-Calais region and the Somme area of France in 1988].
1990
[Probable cutaneous sarcoidosis associated with combined ribavirin and interferon-alpha therapy for chronic hepatitis C].
2000